Featuring an interview with Drs Jeffrey Bradley and David Spigel, including the following topics:
- Clinical Investigator Perspectives on the Management of Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) (0:00)
- Multimodality Management Options for Patients with Unresectable Stage III NSCLC — Jeffrey Bradley, MD (35:46)
- Integration of Immune Checkpoint Inhibition into the Management of Unresectable Stage III NSCLC — David R Spigel, MD (1:03:41)
- Case presentations by Dr Bradley (1:25:27)
- Case Presentations by Dr Spigel (1:37:44)
CME information and select publications